You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation

Citation Tools

Article menu

Download PDFPDF

Cervical cancer
2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
van Trommel N, Kremer W, Dick S, et al
2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation
International Journal of Gynecologic Cancer 2022;32:A49.